Literature DB >> 7143426

Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa.

D S Chitnis, K D Sharma, R S Kamat.   

Abstract

The in-vitro adhesion of Vibrio cholerae to intestinal mucous membrane was studied in isolated adult-rabbit ileal loops. Antisomatic antiserum Against V. cholerae Inaba could inhibit adhesion of three different strains of V. cholerae Inaba but had no effect on the adhesion of two different strains of enterotoxigenic NAG vibrios. The antiserum's bacterial agglutinin titre was 320, its anti-Inaba lipopolysaccharide (LPS) titre was 16 000 and its anti-flagellar antibody titre was 3200. Conversely, anti-live V. Cholerae Inaba antiserum absorbed with boiled cells of Inaba and devoid of antisomatic antibody, could not inhibit adhesion of the same three strains of V. cholerae Inaba. This antiserum had no anti-LPS or bacterial agglutinin activity, but its anti-flagellar antibody titre was 32 000. Thus, ability to inhibit adhesion of V. cholerae could be correlated only with antisomatic (anti-LPS) antibody activity. Antisomatic antiserum had no activity against 'adhesion', a V. cholerae surface antigen described by Freter. Conversely anti-live V. cholerae antiserum absorbed with boiled cells showed anti-adhesion activity even at a dilution of 1 in 200. LPS preparations from V. cholerae strain 569B Inaba could inhibit adhesion of two different Inaba strains to the intestinal mucous membrane. It is concluded that the somatic antigen plays a major role in the adhesion of V. cholerae to the intestinal mucous membrane.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143426     DOI: 10.1099/00222615-15-1-53

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Demonstration of lipopolysaccharide on sheathed flagella of Vibrio cholerae O:1 by protein A-gold immunoelectron microscopy.

Authors:  J A Fuerst; J W Perry
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

2.  Purification and characterization of novel hemagglutinins from Vibrio mimicus: a 39-kilodalton major outer membrane protein and lipopolysaccharide.

Authors:  M Alam; S I Miyoshi; K I Tomochika; S Shinoda
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 3.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice.

Authors:  C K Lee; R Weltzin; G Soman; K M Georgakopoulos; D M Houle; T P Monath
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

Review 5.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

Review 6.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

Review 7.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  Intestinal adherence of Vibrio cholerae involves a coordinated interaction between colonization factor GbpA and mucin.

Authors:  Rudra Bhowmick; Abhisek Ghosal; Bhabatosh Das; Hemanta Koley; Dhira Rani Saha; Sandipan Ganguly; Ranjan K Nandy; Rupak K Bhadra; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization.

Authors:  D K Sengupta; T K Sengupta; A C Ghose
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.

Authors:  G A Losonsky; J Yunyongying; V Lim; M Reymann; Y L Lim; S S Wasserman; M M Levine
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.